These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5066843)

  • 1. Effect of adrenergic blocking agents on insulin response to glucose infusion in man.
    Cerasi E; Luft R; Efendić S
    Acta Endocrinol (Copenh); 1972 Feb; 69(2):335-46. PubMed ID: 5066843
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
    Imura H; Kato Y; Ikeda M; Morimoto M; Yawata M
    J Clin Invest; 1971 May; 50(5):1069-79. PubMed ID: 4928263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenergic modulation of basal insulin secretion in man.
    Robertson RP; Porte D
    Diabetes; 1973 Jan; 22(1):1-8. PubMed ID: 4683792
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of adrenergic receptors in glucose-induced insulin secretion in man.
    Cerasi E; Effendic S; Luft R
    Lancet; 1969 Aug; 2(7615):301-2. PubMed ID: 4184216
    [No Abstract]   [Full Text] [Related]  

  • 5. Antagonism between glucose and epinephrine regarding insulin secretion. A dose-response study in man.
    Cerasi E; Luft R; Efendić S
    Acta Med Scand; 1971 Nov; 190(5):411-7. PubMed ID: 4337656
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial: beta-adrenoceptors and glucose receptors in pancreatic beta cells.
    Vaisrub S
    JAMA; 1975 May; 232(8):836-7. PubMed ID: 235659
    [No Abstract]   [Full Text] [Related]  

  • 7. The pharmacology of a new hypoglycaemic agent N-[4-(2-(2,3-dihydrobenzo (b) furan-7-carboxamido)-ethyl)-benzenesulphonyl]-N'-cyclohexylurea (NOVO CS 476). II. Pharmacological studies on the mechanism of action.
    Jorgensen KD
    Acta Pharmacol Toxicol (Copenh); 1977 Feb; 40(2):227-33. PubMed ID: 190857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of alpha- and beta adrenergic receptor blockaders on the secretory response of pancreatic beta cells in thyrotoxicosis].
    Zhurova TE; Lugovaia NA; Poltorak VV; Iurchenko MZ
    Ter Arkh; 1982; 54(10):36-9. PubMed ID: 6129711
    [No Abstract]   [Full Text] [Related]  

  • 9. Adrenergic modulation of glucagon and insulin secretion in obese and lean humans.
    Atkinson RL; Dahms WT; Bray GA; Sperling MA
    Horm Metab Res; 1981 May; 13(5):249-53. PubMed ID: 7021385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-adrenergic stimulation contributes to incretin effect in conscious dogs.
    Chap Z; Okuda Y; Peña J; Field JB
    Am J Physiol; 1991 Jul; 261(1 Pt 1):E58-65. PubMed ID: 1650140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenergic effects which modify arginine-induced insulin release in man.
    Floyd JC; Fajans SS; Pek S; Knopf RF; Weissman P; Conn JW
    J Lab Clin Med; 1971 Dec; 78(6):990-1. PubMed ID: 5131871
    [No Abstract]   [Full Text] [Related]  

  • 12. [Direct pharmacological proof that beta-adrenergic receptors involved in the insulin secretion are of the beta-2 type].
    Mariani MM; Loubatières A
    C R Acad Hebd Seances Acad Sci D; 1970 Sep; 271(12):1046-8. PubMed ID: 4394637
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of various adrenergic receptor stimulating and blocking agents on human growth hormone secretion.
    Massara F; Camanni F
    J Endocrinol; 1972 Aug; 54(2):195-206. PubMed ID: 4403626
    [No Abstract]   [Full Text] [Related]  

  • 15. [Autonomic nervous system and secretion of insulin. II. Effect of adrenergic blockaders on the insulin secretion in response to tolbutamide].
    Carducci Artenisio A; Albanese MC; Allegra V; Alibrando S; Sprovieri M; Caruso A; Corsi V
    Folia Endocrinol; 1972 Dec; 25(6):467-85. PubMed ID: 4354623
    [No Abstract]   [Full Text] [Related]  

  • 16. The adrenergic modulation of the serum insulin response to intravenous arginine in man.
    London DR; Bacchus RA; Bold AM; Meade L; Sacre M; Taberner M; Walker G
    Eur J Clin Invest; 1971 Nov; 2(1):52-8. PubMed ID: 5156957
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of an adenosine--3'5'--monophosphate diesterase inhibitor (aminophylline) on the insulin response to glucose infusion in prediabetic and diabetic subjects.
    Cerasi E; Luft R
    Horm Metab Res; 1969 Jul; 1(4):162-8. PubMed ID: 4334871
    [No Abstract]   [Full Text] [Related]  

  • 18. Blood sugar responses to epinephrine in the dog in the presence of dual adrenergic blockade.
    Nash CB; Smith RD
    Eur J Pharmacol; 1972 Jan; 17(1):34-8. PubMed ID: 4401432
    [No Abstract]   [Full Text] [Related]  

  • 19. Depressed tolbutamide-induced insulin response in subjects treated with propranolol.
    Massara F; Strumia E; Camanni F; Molinatti GM
    Diabetologia; 1971 Aug; 7(4):287-9. PubMed ID: 5093710
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of adrenergic blockade on the insulin release after intraduodenal glucose in man.
    Flaten O; Sand T; Myren J
    Acta Physiol Scand; 1981; 113(3):415-6. PubMed ID: 6125087
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.